comparemela.com

Page 20 - Resistant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innocan Pharma Corporation: Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment

A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant) epilepsyThe dog was frequently hospitalized to stop seizure clusters Following

Global Treatment Resistant Depression Market to Surpass US$ 1,545 6 Million by 2030

SEATTLE, Sept. 5, 2022 /PRNewswire/ According to Coherent Market Insights, the global treatment resistant depression market is estimated to be valued at US$ 1,180.0 million in 2022 and is

United BioPharma Inc : NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421

TAIPEI, Aug. 31, 2022 /PRNewswire/ United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.